Patents by Inventor Ali HUSSAIN

Ali HUSSAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11119183
    Abstract: A sparse DOA estimation is based on a multi-level prime arrays (MLPAs) as a general structure for coprime arrays. The array uses multiple uniform subarrays “or levels” where the number of antenna elements of the subarrays are pairwise coprime integers. The subarrays overlap only at their first antenna element by adjusting the inter-element spacing. By selecting the number of antennas of the subarrays and controlling the inter-element spacing, various MLPAs of different features can be constructed. The configuration that realizes the maximum number of unique lags is recommended because the DOF is upper bounded by the number of lags.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: September 14, 2021
    Assignee: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
    Inventors: Saleh Ahmed Alawsh, Ali Hussain Muqaibel
  • Publication number: 20210239995
    Abstract: Described are various embodiments of space-compressing methods, materials, devices, and systems, and imaging or optical devices and systems using same. In one embodiment, an optical system comprises an optical convergence element having a defined optical path convergence distance and disposed so to produce converging optical rays along an optical convergence path to converge at said distance; an optical space-compression medium disposed along the optical convergence path to intersect the converging optical rays to compress a resulting optical convergence distance by imparting an inward transverse translation of the converging optical rays while substantially maintaining respective incident convergence angles upon output.
    Type: Application
    Filed: February 2, 2021
    Publication date: August 5, 2021
    Inventors: Jeffrey Stephen Lundeen, Robert William Boyd, Orad Reshef, Michael Patrick Delmastro, Ali Hussain H. Alhulaymi, Lambert Giner, Katherine Karla Misaye Bearne, Jordan Theodore Roger PAGÉ
  • Publication number: 20210100935
    Abstract: A method of manufacturing a medical product having an engineered heparin bioactive matrix for clinical application on a blood contacting surface comprises: a) activating a blood contacting surface of at least one component of a medical device via one of plasma treatment or gas activation; b) assembling the medical product; c) Setting up medical device for wet chemistry in which wet chemistry treatments follows a blood flow path through device; d) enhancing at least the blood contacting surface with a wet chemistry treatment including an aqueous solution having a strong oxidizing agent, such as ammonium persulfate; e) adding a positively charged spacer molecule to at least the blood contacting surface with a wet chemistry treatment including an aqueous solution having a cationic polymer, such as PEI; and f) covalently immobilizing heparin to at least the blood contacting surface with a wet chemistry treatment including heparin, preferably deaminated heparin.
    Type: Application
    Filed: October 20, 2020
    Publication date: April 8, 2021
    Inventors: Ali Hussain, Linda Cahalan, Patrick Cahalan
  • Patent number: 10940168
    Abstract: A composition includes a sea cucumber and ginseng/red ginseng composite extract which has the effect of regenerating the Bruch's membrane of the eye and improving the transport function of the Bruch's membrane. The composite composition improves the transport function of the Bruch's membrane and eliminates lipids accumulated on the membrane to promote the regeneration of the Bruch's membrane, thereby showing the effect of delaying or reversing the senescence process of the eye. Further, the composition is highly preventive or therapeutic of various diseases attributed to a decrease in the function of the Bruch's membrane with age, including age-related macular degeneration (AMD) and can solve the problem associated with the eye health maintenance of ordinary persons and with the transport reduction, resulting from senescence, of vitamins, metals, and anti-oxidative materials.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: March 9, 2021
    Assignee: ALTREGEN CO., LTD.
    Inventors: Yunhee Lee, Ali Hussain, Dae Bong Kim
  • Publication number: 20210007896
    Abstract: A method of preparing a crosslinked, collagen-based wound care dressing is provided, comprising: (a) immersing a sample of fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution comprising an alcohol; (b) contacting the collagen in solution with a catalytic component comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride for a time at least sufficient to effect reaction between amino and carboxyl groups present on the collagen and to yield crosslinked collagen that is resistant to pronase degradation; and (c) drying the crosslinked collagen to yield a porous, crosslinked collagen article wherein the porous, crosslinked collagen article demonstrates a pore size of 10-500 microns. Also provided are bioactive collagen medical scaffolds for hernia repair prosthetics and surgical incision closure members, prepared using the method above.
    Type: Application
    Filed: August 17, 2020
    Publication date: January 14, 2021
    Inventors: Ali Hussain, Patrick Cahalan, Linda Cahalan
  • Publication number: 20200397670
    Abstract: A composition for healing or improving skin includes a fabric or material impregnated with an oxygen generating material. The fabric may include a first side in contact with the skin for providing oxygen to the skin and a second side between the oxygen generating material and the air surrounding the skin to form a barrier for retaining heat and inhibiting evaporation.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: Andrew J. Carter, Melissa Jochim, Bradley E. Patt, Ali Hussain
  • Patent number: 10781195
    Abstract: A method to produce 5-hydroxymethylfurfural (HMF) from C6 carbohydrates. The method includes the steps of reacting a reactant comprising at least one C6 carbohydrate, in a reaction mixture comprising at least about 5% (v/v) water, a polar, aprotic solvent, and an acid, for a time, at a temperature, and at a hydrogen ion concentration wherein at least a portion of the C6 carbohydrate present in the reactant is converted to 5-hydroxymethyl furfural (“HMF”).
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: September 22, 2020
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: James A. Dumesic, Ali Hussain Motagamwala
  • Patent number: 10744039
    Abstract: A method of preparing a crosslinked, collagen-based wound care dressing is provided, comprising: (a) immersing a sample of fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution comprising an alcohol; (b) contacting the collagen in solution with a catalytic component comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride for a time at least sufficient to effect reaction between amino and carboxyl groups present on the collagen and to yield crosslinked collagen that is resistant to pronase degradation; and (c) drying the crosslinked collagen to yield a porous, crosslinked collagen article wherein the porous, crosslinked collagen article demonstrates a pore size of 10-500 microns. Also provided are bioactive collagen medical scaffolds for hernia repair prosthetics and surgical incision closure members, prepared using the method above.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: August 18, 2020
    Assignee: ENSION INC.
    Inventors: Ali Hussain, Patrick Cahalan, Linda Cahalan
  • Publication number: 20200230037
    Abstract: A system and method are disclosed for infusing a gas into a composition for treating skin, the system including a source of gas, a container for holding the composition, and a means of communication with the source of gas for delivering the gas to the container.
    Type: Application
    Filed: August 8, 2018
    Publication date: July 23, 2020
    Inventors: Bradley E. Patt, Andrew J. Carter, Ali Hussain
  • Publication number: 20200200861
    Abstract: A sparse DOA estimation is based on a multi-level prime arrays (MLPAs) as a general structure for coprime arrays. The array uses multiple uniform subarrays “or levels” where the number of antenna elements of the subarrays are pairwise coprime integers. The subarrays overlap only at their first antenna element by adjusting the inter-element spacing. By selecting the number of antennas of the subarrays and controlling the inter-element spacing, various MLPAs of different features can be constructed. The configuration that realizes the maximum number of unique lags is recommended because the DOF is upper bounded by the number of lags.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 25, 2020
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Saleh Ahmed ALAWSH, Ali Hussain Muqaibel
  • Publication number: 20200039947
    Abstract: A method to produce 5-hydroxymethylfurfural (HMF) from C6 carbohydrates. The method includes the steps of reacting a reactant comprising at least one C6 carbohydrate, in a reaction mixture comprising at least about 5% (v/v) water, a polar, aprotic solvent, and an acid, for a time, at a temperature, and at a hydrogen ion concentration wherein at least a portion of the C6 carbohydrate present in the reactant is converted to 5-hydroxymethyl furfural (“HMF”).
    Type: Application
    Filed: July 31, 2018
    Publication date: February 6, 2020
    Inventors: James A. Dumesic, Ali Hussain Motagamwala
  • Publication number: 20200023016
    Abstract: A composition includes a sea cucumber and ginseng/red ginseng composite extract which has the effect of regenerating the Bruch's membrane of the eye and improving the transport function of the Bruch's membrane. The composite composition improves the transport function of the Bruch's membrane and eliminates lipids accumulated on the membrane to promote the regeneration of the Bruch's membrane, thereby showing the effect of delaying or reversing the senescence process of the eye. Further, the composition is highly preventive or therapeutic of various diseases attributed to a decrease in the function of the Bruch's membrane with age, including age-related macular degeneration (AMD) and can solve the problem associated with the eye health maintenance of ordinary persons and with the transport reduction, resulting from senescence, of vitamins, metals, and anti-oxidative materials.
    Type: Application
    Filed: February 8, 2018
    Publication date: January 23, 2020
    Inventors: Yunhee LEE, Ali HUSSAIN, Dae Bong KIM
  • Patent number: 10456227
    Abstract: A method of treating a tubular medical device with a biomolecule comprises the steps of: a) providing a polyolefin tubular substrate forming a tubular medical device; b) cleaning the tubular polyolefin substrate; c) exposing the tubular polyolefin substrate to a reactive gas containing at least one of acrylic acid and siloxane and to plasma energy to yield a plasma-deposited coating on at least one surface of the tubular polyolefin substrate; and d) attaching a biomolecule to the polyolefin substrate following formation of the plasma-deposited coating on at least one surface of the tubular polyolefin substrate, and wherein the biomolecule is at least one of an antibacterial agent, antimicrobial agent, anticoagulant, heparin, antithrombotic agent, platelet agent, anti-inflammatory, enzyme, catalyst, hormone, growth factor, drug, vitamin, antibody, antigen, protein, nucleic acid, dye, a DNA segment, an RNA segment, protein, and peptide.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: October 29, 2019
    Assignee: ENSION INC.
    Inventors: Ali Hussain, Linda Cahalan, Greg Johnson, Mark Gartner, Patrick Cahalan, Brian J Fill, Jeffrey W. Speakman
  • Publication number: 20190321381
    Abstract: The present invention relates to a composition for preventing and treating a Bruch's membrane dysfunction-associated disease, which includes a sea cucumber extract as an active ingredient, and more particularly, to a composition for preventing and treating a Bruch's membrane dysfunction-associated disease, which includes a sea cucumber extract having effects of regenerating the Bruch's membrane of an eye and improving a transport function. The composition according to the present invention improves the transport function of the Bruch's membrane and promotes the regeneration of the Bruch's membrane, thereby delaying or reversing an eye aging process, and thus has excellent effects on the prevention and treatment of a disease such as age-related macular degeneration (AMD), Sorsby's fundus dystrophy, Malattia Levintanese (ML), Stargardt disease, Best's vitelliform retinal dystrophy and Doyne's honeycomb retinal dystrophy (DHRD), which occurs due to the age-related dysfunction of the Bruch's membrane.
    Type: Application
    Filed: December 18, 2017
    Publication date: October 24, 2019
    Applicant: ALTREGEN CO., LTD.
    Inventors: Yunhee LEE, Ali HUSSAIN, Dae Bong KIM
  • Publication number: 20190134263
    Abstract: The present invention relates to a vascularized three dimensional construct for thick tissue, a process for making the construct and to the use of the construct in tissue regeneration and repair and in drug development. The three-dimensional (3-D) tissue technology is used to generate vascularized, biomimetic tissue models in vitro utilizing a biodegradable nanofiber scaffold. The culture system allows the maintenance of long-term survival and function of liver and heart cells. The system utilizes a novel approach to generate structures that mimic in vivo tissue architecture. The system provides a microenvironment for forming 3-D microvascular networks within the nanofiber scaffolds.
    Type: Application
    Filed: March 1, 2012
    Publication date: May 9, 2019
    Inventors: Cheul H Cho, Ali Hussain, George Collins, Divya Ranendran
  • Publication number: 20180125620
    Abstract: A method of treating a tubular medical device with a biomolecule comprises the steps of: a) providing a polyolefin tubular substrate forming a tubular medical device; b) cleaning the tubular polyolefin substrate; c) exposing the tubular polyolefin substrate to a reactive gas containing at least one of acrylic acid and siloxane and to plasma energy to yield a plasma-deposited coating on at least one surface of the tubular polyolefin substrate; and d) attaching a biomolecule to the polyolefin substrate following formation of the plasma-deposited coating on at least one surface of the tubular polyolefin substrate, and wherein the biomolecule is at least one of an antibacterial agent, antimicrobial agent, anticoagulant, heparin, antithrombotic agent, platelet agent, anti-inflammatory, enzyme, catalyst, hormone, growth factor, drug, vitamin, antibody, antigen, protein, nucleic acid, dye, a DNA segment, an RNA segment, protein, and peptide.
    Type: Application
    Filed: July 3, 2017
    Publication date: May 10, 2018
    Inventors: Ali Hussain, Linda Cahalan, Greg Johnson, Mark Gartner, Patrick Cahalan, Brian J. Fill, Jeffrey W. Speakman
  • Publication number: 20180064580
    Abstract: A method of preparing a crosslinked, collagen-based wound care dressing is provided, comprising: (a) immersing a sample of fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution comprising an alcohol; (b) contacting the collagen in solution with a catalytic component comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride for a time at least sufficient to effect reaction between amino and carboxyl groups present on the collagen and to yield crosslinked collagen that is resistant to pronase degradation; and (c) drying the crosslinked collagen to yield a porous, crosslinked collagen article wherein the porous, crosslinked collagen article demonstrates a pore size of 10-500 microns. Also provided are bioactive collagen medical scaffolds for hernia repair prosthetics and surgical incision closure members, prepared using the method above.
    Type: Application
    Filed: October 23, 2017
    Publication date: March 8, 2018
    Inventors: Ali HUSSAIN, Patrick Cahalan, Linda Cahalan
  • Patent number: 9796769
    Abstract: A method of preparing a crosslinked, collagen-based medical scaffold is provided, comprising: (a) immersing a sample of fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution comprising an alcohol; (b) contacting the collagen in solution with a catalytic component comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride for a time at least sufficient to effect reaction between amino and carboxyl groups present on the collagen and to yield crosslinked collagen that is resistant to pronase degradation; and (c) drying the crosslinked collagen to yield a porous, crosslinked collagen article wherein the porous, crosslinked collagen article demonstrates a pore size of 10-500 microns. Also provided are bioactive collagen medical scaffolds for wound care dressings, hernia repair prosthetics, and surgical incision closure members, prepared using the method above.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: October 24, 2017
    Assignee: ENSION INC.
    Inventors: Ali Hussain, Patrick Cahalan, Linda Cahalan
  • Patent number: 9693841
    Abstract: A variety of medical devices including staples sutures and dental floss with surface treatment on at least one tissue-facing surface to improve biologic function such as to control tissue adhesion are disclosed including heparin surface treatment which provides heparin present in an amount to yield heparin bioactivity of at least one of i) an ATIII binding of at least 2 pmol/cm2, and ii) a thrombin deactivation of at least 0.2 IU/cm2; an acrylic surface treatment for coupling thereto of a heparin surface treatment, a collagen surface treatment or both; and an amino-functional polysiloxane surface treatment for coupling thereto of a heparin surface treatment.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 4, 2017
    Assignee: ENSION, INC.
    Inventors: Ali Hussain, Linda Cahalan, Greg Johnson, Mark Gartner, Patrick Cahalan, Brian J Fill, Jeffrey W. Speakman
  • Patent number: D904450
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: December 8, 2020
    Assignee: Square, Inc.
    Inventors: Brandon Jacoby, Owen Jennings, Ali Hussain